- cafead   Oct 26, 2022 at 11:02: AM
via Seres Therapeutics’ SER-109 has faced more setbacks than most drugs, but the biotech has kept the faith and is now tantalizingly close to possibly seeing its candidate become the first FDA-approved oral microbiome therapeutic.
article source
article source